Medical school
Vanderbilt University School of Medicine[1]
Through 2016
Glynnis Garry
Assistant Professor
UT Southwestern Medical Center · Date not established · Last known relationship
Assistant Professor
UT Southwestern Medical Center · Date not established · Last known relationship
Conflicting evidence. The roster card lists the name as Glynnis Garry, while the individual profile uses Glynnis Garry Bann.
A physician-scientist, she investigates therapies for heart failure and myocardial infarction through studies of cardiac development, cell fate, and fibroblast-to-cardiomyocyte reprogramming.
Garry Bann completed medical training at Vanderbilt and physician-scientist residency, research, and cardiology fellowship training at UT Southwestern and Parkland. She joined the UT Southwestern faculty in 2024.
Her laboratory studies transcriptional and epigenetic control of heart development and cardiac cell differentiation, with an emphasis on direct cardiac reprogramming and regenerative approaches to heart failure and myocardial infarction.
cardiac cell fate differentiation · cardiac regeneration · epigenetic regulation · fibroblast-to-cardiomyocyte reprogramming · heart development · heart failure · myocardial infarction · transcriptional regulation
Reviewed sources document Medical school: Vanderbilt University School of Medicine, Residency: UT Southwestern Medical Center (Internal Medicine), and Fellowship: UT Southwestern Medical Center (Cardiology).
Explore education and trainingReviewed sources document cardiac cell fate differentiation, cardiac regeneration, epigenetic regulation, and fibroblast-to-cardiomyocyte reprogramming, plus 4 more research items. Explore attributed publications and research affiliations.
Explore researchDated relationships supported by published source records. Inferred dates are labeled.
Date not established
UT Southwestern Medical Center
UT Southwestern Division of Cardiology faculty directorycardiac cell fate differentiation[1]
cardiac regeneration[1]
epigenetic regulation[1]
fibroblast-to-cardiomyocyte reprogramming[1]
heart development[1]
heart failure[1]
myocardial infarction[1]
transcriptional regulation[1]
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
17 source claims · Reviewed Sep 7, 2026
Biographical context: A physician-scientist, she investigates therapies for heart failure and myocardial infarction through studies of cardiac development, cell fate, and fibroblast-to-cardiomyocyte reprogramming.
Biography Glynnis Garry Bann, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. She holds a secondary appointment in the Deparment of Molecular Biology and the Center for Regenerative Science and Medicine. Dr. Bann holds a bachelor's degree from the University of Notre Dame in Indiana and earned her medical degree at Vanderbilt University School of Medicine in Tennessee, where she graduated Alpha Omega Alpha. She received molecular biology training at UT Southwestern in the laboratory of Eric Olson, Ph.D., after being awarded the Sarnoff Cardiovascular Research fellowship. She then completed internal medicine residency training, postdoctoral research fellowship training, and clinical cardiology fellowship training through the Physician-Scientist Training Program (PSTP) at UT Southwestern and Parkland Health. Certified by the American Board of Internal Medicine, Dr. Bann joined the UT Southwestern faculty in 2024. As a physician-scientist, Dr. Bann’s research interests are focused on discovery of therapies for heart failure and myocardial infarction. Her NIH-funded laboratory focuses on the transcriptional and epigenetic control of heart development and cardiac cell fate differentiation, with a focus on direct fibroblast-to-cardiomyocyte reprogramming. Her investigations have resulted in numerous peer-reviewed publications, book chapters, patents, and presentations at national and international scientific conferences. Dr. Bann has received a number of awards for her research, including the Donald W. Seldin Research Scholar, the Astra-Zeneca Northwestern Cardiovascular Young Investigator Award, and the Burroughs Wellcome Fund Career Award for Medical Scientists. She was awarded the prestigious Louis N. and Arnold M. Katz Basic Science Research Prize in 2020 and the Melvin L. Marcus Early Career Investigator Award in 2023 by the American Heart Association. Dr. Bann is active in several professional societies, including the American Heart Association, the Stanley Sarnoff Cardiovascular Research Foundation, and the International Society for Heart Research.
Biographical context: Garry Bann completed medical training at Vanderbilt and physician-scientist residency, research, and cardiology fellowship training at UT Southwestern and Parkland. She joined the UT Southwestern faculty in 2024.
Biography Glynnis Garry Bann, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. She holds a secondary appointment in the Deparment of Molecular Biology and the Center for Regenerative Science and Medicine. Dr. Bann holds a bachelor's degree from the University of Notre Dame in Indiana and earned her medical degree at Vanderbilt University School of Medicine in Tennessee, where she graduated Alpha Omega Alpha. She received molecular biology training at UT Southwestern in the laboratory of Eric Olson, Ph.D., after being awarded the Sarnoff Cardiovascular Research fellowship. She then completed internal medicine residency training, postdoctoral research fellowship training, and clinical cardiology fellowship training through the Physician-Scientist Training Program (PSTP) at UT Southwestern and Parkland Health. Certified by the American Board of Internal Medicine, Dr. Bann joined the UT Southwestern faculty in 2024. As a physician-scientist, Dr. Bann’s research interests are focused on discovery of therapies for heart failure and myocardial infarction. Her NIH-funded laboratory focuses on the transcriptional and epigenetic control of heart development and cardiac cell fate differentiation, with a focus on direct fibroblast-to-cardiomyocyte reprogramming. Her investigations have resulted in numerous peer-reviewed publications, book chapters, patents, and presentations at national and international scientific conferences. Dr. Bann has received a number of awards for her research, including the Donald W. Seldin Research Scholar, the Astra-Zeneca Northwestern Cardiovascular Young Investigator Award, and the Burroughs Wellcome Fund Career Award for Medical Scientists. She was awarded the prestigious Louis N. and Arnold M. Katz Basic Science Research Prize in 2020 and the Melvin L. Marcus Early Career Investigator Award in 2023 by the American Heart Association. Dr. Bann is active in several professional societies, including the American Heart Association, the Stanley Sarnoff Cardiovascular Research Foundation, and the International Society for Heart Research.
Biographical context: Her laboratory studies transcriptional and epigenetic control of heart development and cardiac cell differentiation, with an emphasis on direct cardiac reprogramming and regenerative approaches to heart failure and myocardial infarction.
Biography Glynnis Garry Bann, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. She holds a secondary appointment in the Deparment of Molecular Biology and the Center for Regenerative Science and Medicine. Dr. Bann holds a bachelor's degree from the University of Notre Dame in Indiana and earned her medical degree at Vanderbilt University School of Medicine in Tennessee, where she graduated Alpha Omega Alpha. She received molecular biology training at UT Southwestern in the laboratory of Eric Olson, Ph.D., after being awarded the Sarnoff Cardiovascular Research fellowship. She then completed internal medicine residency training, postdoctoral research fellowship training, and clinical cardiology fellowship training through the Physician-Scientist Training Program (PSTP) at UT Southwestern and Parkland Health. Certified by the American Board of Internal Medicine, Dr. Bann joined the UT Southwestern faculty in 2024. As a physician-scientist, Dr. Bann’s research interests are focused on discovery of therapies for heart failure and myocardial infarction. Her NIH-funded laboratory focuses on the transcriptional and epigenetic control of heart development and cardiac cell fate differentiation, with a focus on direct fibroblast-to-cardiomyocyte reprogramming. Her investigations have resulted in numerous peer-reviewed publications, book chapters, patents, and presentations at national and international scientific conferences. Dr. Bann has received a number of awards for her research, including the Donald W. Seldin Research Scholar, the Astra-Zeneca Northwestern Cardiovascular Young Investigator Award, and the Burroughs Wellcome Fund Career Award for Medical Scientists. She was awarded the prestigious Louis N. and Arnold M. Katz Basic Science Research Prize in 2020 and the Melvin L. Marcus Early Career Investigator Award in 2023 by the American Heart Association. Dr. Bann is active in several professional societies, including the American Heart Association, the Stanley Sarnoff Cardiovascular Research Foundation, and the International Society for Heart Research.
Fellowship: UT Southwestern Medical Center (Cardiology)
Through 2024
Education Medical Education Vanderbilt University School of Medicine (2016) Residency UT Southwestern Medical Center (2018), Internal Medicine Fellowship UT Southwestern Medical Center (2024), Cardiology
Official headshot: Portrait
<img src="https://profileplus.swmed.edu/facultydata/158451/images/garry-glynnis-inset.jpg" class="card__image" itemprop="image" alt="Glynnis Garry, M.D. " style="max-width:200px;" />
Medical school: Vanderbilt University School of Medicine
Through 2016
Education Medical Education Vanderbilt University School of Medicine (2016) Residency UT Southwestern Medical Center (2018), Internal Medicine Fellowship UT Southwestern Medical Center (2024), Cardiology
Official profile: Official profile
Biography Glynnis Garry Bann, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. She holds a secondary appointment in the Deparment of Molecular Biology and the Center for Regenerative Science and Medicine. Dr. Bann holds a bachelor's degree from the University of Notre Dame in Indiana and earned her medical degree at Vanderbilt University School of Medicine in Tennessee, where she graduated Alpha Omega Alpha. She received molecular biology training at UT Southwestern in the laboratory of Eric Olson, Ph.D., after being awarded the Sarnoff Cardiovascular Research fellowship. She then completed internal medicine residency training, postdoctoral research fellowship training, and clinical cardiology fellowship training through the Physician-Scientist Training Program (PSTP) at UT Southwestern and Parkland Health. Certified by the American Board of Internal Medicine, Dr. Bann joined the UT Southwestern faculty in 2024. As a physician-scientist, Dr. Bann’s research interests are focused on discovery of therapies for heart failure and myocardial infarction. Her NIH-funded laboratory focuses on the transcriptional and epigenetic control of heart development and cardiac cell fate differentiation, with a focus on direct fibroblast-to-cardiomyocyte reprogramming. Her investigations have resulted in numerous peer-reviewed publications, book chapters, patents, and presentations at national and international scientific conferences. Dr. Bann has received a number of awards for her research, including the Donald W. Seldin Research Scholar, the Astra-Zeneca Northwestern Cardiovascular Young Investigator Award, and the Burroughs Wellcome Fund Career Award for Medical Scientists. She was awarded the prestigious Louis N. and Arnold M. Katz Basic Science Research Prize in 2020 and the Melvin L. Marcus Early Career Investigator Award in 2023 by the American Heart Association. Dr. Bann is active in several professional societies, including the American Heart Association, the Stanley Sarnoff Cardiovascular Research Foundation, and the International Society for Heart Research.
Research interests: cardiac cell fate differentiation
As a physician-scientist, Dr. Bann’s research interests are focused on discovery of therapies for heart failure and myocardial infarction. Her NIH-funded laboratory focuses on the transcriptional and epigenetic control of heart development and cardiac cell fate differentiation, with a focus on direct fibroblast-to-cardiomyocyte reprogramming. Her investigations have resulted in numerous peer-reviewed publications, book chapters, patents, and presentations at national and international scientific conferences.
Research interests: cardiac regeneration
Glynnis Garry Bann, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. She holds a secondary appointment in the Deparment of Molecular Biology and the Center for Regenerative Science and Medicine.
Research interests: epigenetic regulation
Glynnis Garry Bann, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. She holds a secondary appointment in the Deparment of Molecular Biology and the Center for Regenerative Science and Medicine.
Research interests: fibroblast-to-cardiomyocyte reprogramming
As a physician-scientist, Dr. Bann’s research interests are focused on discovery of therapies for heart failure and myocardial infarction. Her NIH-funded laboratory focuses on the transcriptional and epigenetic control of heart development and cardiac cell fate differentiation, with a focus on direct fibroblast-to-cardiomyocyte reprogramming. Her investigations have resulted in numerous peer-reviewed publications, book chapters, patents, and presentations at national and international scientific conferences.
Research interests: heart development
As a physician-scientist, Dr. Bann’s research interests are focused on discovery of therapies for heart failure and myocardial infarction. Her NIH-funded laboratory focuses on the transcriptional and epigenetic control of heart development and cardiac cell fate differentiation, with a focus on direct fibroblast-to-cardiomyocyte reprogramming. Her investigations have resulted in numerous peer-reviewed publications, book chapters, patents, and presentations at national and international scientific conferences.
Research interests: heart failure
As a physician-scientist, Dr. Bann’s research interests are focused on discovery of therapies for heart failure and myocardial infarction. Her NIH-funded laboratory focuses on the transcriptional and epigenetic control of heart development and cardiac cell fate differentiation, with a focus on direct fibroblast-to-cardiomyocyte reprogramming. Her investigations have resulted in numerous peer-reviewed publications, book chapters, patents, and presentations at national and international scientific conferences.
Research interests: myocardial infarction
As a physician-scientist, Dr. Bann’s research interests are focused on discovery of therapies for heart failure and myocardial infarction. Her NIH-funded laboratory focuses on the transcriptional and epigenetic control of heart development and cardiac cell fate differentiation, with a focus on direct fibroblast-to-cardiomyocyte reprogramming. Her investigations have resulted in numerous peer-reviewed publications, book chapters, patents, and presentations at national and international scientific conferences.
Research interests: transcriptional regulation
Glynnis Garry Bann, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. She holds a secondary appointment in the Deparment of Molecular Biology and the Center for Regenerative Science and Medicine.
Residency: UT Southwestern Medical Center (Internal Medicine)
Through 2018
Education Medical Education Vanderbilt University School of Medicine (2016) Residency UT Southwestern Medical Center (2018), Internal Medicine Fellowship UT Southwestern Medical Center (2024), Cardiology
Resource: Bann Lab Site
<a href="https://labs.utsouthwestern.edu/bann-lab">Bann Lab Site</a>
1 source claim · Reviewed Sep 7, 2026
Professional role: Assistant Professor
Glynnis Garry, M.D. Assistant Professor
